We are excited to announce that Yellowbird Diagnostics has been selected as a finalist for the 14th annual LiONS LAIR pitch competition! 🦁 After completing the #FoundersFastTrack program with Innovation Factory , we will be competing alongside 9 other finalists in the #LiONSLAIR2024 pitch competition. We can't wait to present our innovations to an audience of 350 industry leaders! See the official press release here: https://lnkd.in/e2hVMetm
Yellowbird Diagnostics, Inc.
Biotechnology Research
Yellowbird Diagnostics develops medical imaging agents that provide molecular information about disease.
About us
Yellowbird Diagnostics, Inc. specializes in biomedical imaging solutions across commonly used clinical imaging technologies. Our imaging solutions aim to empower physicians with actionable diagnostic information earlier in the onset of disease, seamlessly integrating into existing clinical workflows. Our product offerings consist of chemical contrast agents that are tailored to provide molecular information, allowing physicians to identify disease hallmarks before major anatomical changes occur due to inflammation, cancer, or other diseases.
- Website
-
https://yellowbirddx.com/
External link for Yellowbird Diagnostics, Inc.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Privately Held
- Founded
- 2023
Employees at Yellowbird Diagnostics, Inc.
Updates
-
We are so grateful for this funding from Canadian Medical Isotope Ecosystem that we will use to propel NeuCaVis towards a successful first-in-human trial! This milestone will pave the way for earlier and more accurate diagnoses of neurological and cardiac diseases, fostering timely interventions, personalized treatment strategies, and the development of new therapies. Alexia Kirby Adam Shuhendler Nicholas Calvert
Project Spotlight: Yellowbird Diagnostics, Inc. - Ontario Yellowbird Diagnostics, Inc. creates new diagnostic imaging agents that address gaps in current clinical practices. Neuro- and cardio-inflammation are important indicators for a range of injuries and disease, however current radiotracers cannot adequately detect and map these inflammatory responses. Yellowbird’s first-to-clinic product is NeuCaVis, a unique radiotracer that, for the first time, can map fructolysis as an outcome of inflammatory disease. Funding from CMIEDF will support the manufacturing and regulatory testing of NeuCaVis necessary to ensure a successful first-in-human trial. Ultimately, successful clinical translation will lead to earlier and more accurate diagnosis of neurological and cardiac diseases, enabling timely interventions, personalized treatment strategies, and development of new therapies.
-
-
🎓 Team Yellowbird proudly took center stage at University of Ottawa Faculty of Science convocation last night! 🎓 Alexia Kirby and Nicholas Calvert, now holding their doctorate degrees, were joined on stage by Adam Shuhendler, donning his University of Toronto doctoral robe. 🌟 These milestones mark the culmination of our journey, paving the way for the founding of Yellowbird Diagnostics by the three of us. 🚀 #Convocation #Founders #MilestoneAchievement #uoGrad24
-
-
We are thrilled to announce that Yellowbird Diagnostics secured third place at the #AccelerateOTT Startup World Cup regional pitch competition hosted by Invest Ottawa yesterday! 🎉🏆 This incredible achievement comes with a $10,000 grant prize, which will help us continue advancing our innovative diagnostics solutions. A huge shoutout to all the amazing founders who participated— the competition was fierce. It's an honor to be part of such a vibrant and innovative community! Thank you to Invest Ottawa and all the organizers for creating this fantastic platform to showcase our work. We are excited about the future and look forward to taking Yellowbird Diagnostics to new heights! #StartupWorldCup #InvestOttawa #Innovation #Entrepreneurship
-
-
🌟 Exciting News from Yellowbird Diagnostics! 🌟 We are thrilled to announce the launch of our brand-new website! 🚀 ✨ Visit us at 🔗 https://lnkd.in/eBhP4s53 to explore our innovative solutions, learn more about our cutting-edge diagnostics technology, and stay updated with the latest advancements in the field. We invite you to visit our new online home and discover how Yellowbird Diagnostics is leading the way in diagnostic innovation. Thank you for your continued support! Here's to new beginnings and groundbreaking progress. 🥂
-
🚀 Curious about the groundbreaking work we're doing at Yellowbird? 🌟 Catch our CEO, Nick, delivering a powerful 1-minute pitch at MedTech Innovator in Washington, DC! 🎥 At Yellowbird, we're revolutionizing healthcare with innovative imaging dyes that enable early detection of disease hallmarks. This advancement allows patients to receive timely treatments, resulting in significantly better outcomes. Join us on this journey to transform medical diagnostics and improve patient care! 💡 #MedTech #HealthcareInnovation #EarlyDetection #BetterOutcomes
-
We are thrilled to have been chosen as one of the Top 12 startups to compete in the #AccelerateOTT Ottawa division of the Startup World Cup hosted by Invest Ottawa! 🚀
Cat's out of the bag! 😻 Due to such an incredible number of stellar applicants, we are thrilled to unveil the top 12 companies gearing up to pitch at the #AccelerateOTT Startup World Cup Regional Pitch Competition! 🎤 Here's a sneak peek at the incredible lineup of companies: 🎤 Advanced Symbolics Inc. 🎤 Celestra Health Systems 🎤 Constant Health 🎤 DOT - Mind Unlocked 🎤 Growcer 🎤 Hyperlume Inc. 🎤 LearnExperts 🎤 NotaryPro 🎤 Plantaform 🎤 Realize Medical Inc. 🎤 SmartCocoon 🎤 Yellowbird Diagnostics, Inc. 💰 With $50,000 in non-dilutive grant prizes on the line and the opportunity to compete for a jaw-dropping $1 million USD investment prize at the Global Grand Finale in San Francisco, the stakes have never been higher! 💼 🗓️ Save the Date: June 4th 👀 Get ready to be wowed by our esteemed panel of judges hailing from top-tier Venture Capital firms including Inovia Capital, Staircase Ventures, Graphite Ventures, and BDC’s Seed Fund. A huge thank you to our evaluation committee who had the extremely tough job of whittling down our 70 applicants to 12 finalists. The committee included our very own expert advisors, former founders, and local investors from Capital Angel Network, Graphite Ventures, Mistral Ventures, MaRS Investment Accelerator Fund, L-SPARK Startup Accelerator, Aventure Capital, and Ontario Centre of Innovation. It truly takes a village! Don't miss the chance to witness innovation in action as these 12 trailblazing companies take the stage! 🔗 RSVP now to secure your spot: https://bit.ly/44KsZOw
-
-
Exciting news for Yellowbird Diagnostics, Inc.! We will be presenting at the 2024 Ontario Bioscience Innovation Organization (OBIO) Investment Summit in Toronto, happening February 14-16. We’re thrilled to have the opportunity to showcase our imaging dyes alongside other innovative companies driving advancements in healthcare. https://lnkd.in/d7rUmFB4 #OBIO #OBIOInvestmentSummit
-